IAP
Indie Asset Partners’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-433,000
| Closed | -$12.2M | – | 95 |
|
2023
Q4 | $12.2M | Hold |
433,000
| – | – | 10.97% | 2 |
|
2023
Q3 | $11.8M | Hold |
433,000
| – | – | 11.85% | 2 |
|
2023
Q2 | $13.3M | Hold |
433,000
| – | – | 14.48% | 2 |
|
2023
Q1 | $15.6M | Sell |
433,000
-29,000
| -6% | -$1.04M | 18.22% | 2 |
|
2022
Q4 | $18.3M | Sell |
462,000
-59,750
| -11% | -$2.36M | 20.01% | 2 |
|
2022
Q3 | $21M | Sell |
521,750
-49,838
| -9% | -$2M | 21.48% | 2 |
|
2022
Q2 | $24M | Sell |
571,588
-185,286
| -24% | -$7.79M | 21.21% | 1 |
|
2022
Q1 | $29.5M | Sell |
756,874
-49,108
| -6% | -$1.91M | 22.15% | 1 |
|
2021
Q4 | $32.1M | Buy |
805,982
+104,659
| +15% | +$4.17M | 23.31% | 1 |
|
2021
Q3 | $25.3M | Sell |
701,323
-10,300
| -1% | -$372K | 20.53% | 1 |
|
2021
Q2 | $29.2M | Buy |
711,623
+695,600
| +4,341% | +$28.5M | 23.64% | 1 |
|
2021
Q1 | $699K | Sell |
16,023
-3,695
| -19% | -$161K | 0.8% | 29 |
|
2020
Q4 | $987K | Sell |
19,718
-3,570
| -15% | -$179K | 1.15% | 18 |
|
2020
Q3 | $980K | Buy |
23,288
+13,960
| +150% | +$587K | 1.23% | 17 |
|
2020
Q2 | $427K | Buy |
+9,328
| New | +$427K | 0.54% | 48 |
|